Bastiaannet E - Search Results

1

A prediction tool incorporating the biomarker S-100B for patient selection for completion lymph node dissection in stage III melanoma.

Damude S, Wevers KP, Murali R, Kruijff S, Hoekstra HJ, Bastiaannet E. Damude S, et al. Among authors: bastiaannet e. Eur J Surg Oncol. 2017 Sep;43(9):1753-1759. doi: 10.1016/j.ejso.2017.07.006. Epub 2017 Jul 29. Eur J Surg Oncol. 2017. PMID: 28797756

2

The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis.

Bastiaannet E, Groen H, Jager PL, Cobben DC, van der Graaf WT, Vaalburg W, Hoekstra HJ. Bastiaannet E, et al. Cancer Treat Rev. 2004 Feb;30(1):83-101. doi: 10.1016/j.ctrv.2003.07.004. Cancer Treat Rev. 2004. PMID: 14766127 Review.

3

Radiation therapy following lymph node dissection in melanoma patients: treatment, outcome and complications.

Bastiaannet E, Beukema JC, Hoekstra HJ. Bastiaannet E, et al. Cancer Treat Rev. 2005 Feb;31(1):18-26. doi: 10.1016/j.ctrv.2004.09.005. Epub 2004 Nov 18. Cancer Treat Rev. 2005. PMID: 15707701 Review.

4

Impact of [18F]fluorodeoxyglucose positron emission tomography on surgical management of melanoma patients.

Bastiaannet E, Oyen WJ, Meijer S, Hoekstra OS, Wobbes T, Jager PL, Hoekstra HJ. Bastiaannet E, et al. Br J Surg. 2006 Feb;93(2):243-9. doi: 10.1002/bjs.5174. Br J Surg. 2006. PMID: 16323165

5

[Detection of the first recurrence in patients with melanoma: three quarters by the patient, one quarter during outpatient follow-up].

Francken AB, Thompson JF, Bastiaannet E, Hoekstra HJ. Francken AB, et al. Among authors: bastiaannet e. Ned Tijdschr Geneeskd. 2008 Mar 8;152(10):557-62. Ned Tijdschr Geneeskd. 2008. PMID: 18402322 Dutch.

6

Therapeutic groin dissection for melanoma: risk factors for short term morbidity.

Poos HP, Kruijff S, Bastiaannet E, van Ginkel RJ, Hoekstra HJ. Poos HP, et al. Among authors: bastiaannet e. Eur J Surg Oncol. 2009 Aug;35(8):877-83. doi: 10.1016/j.ejso.2008.10.012. Epub 2008 Dec 2. Eur J Surg Oncol. 2009. PMID: 19054644

7

S-100B concentrations predict disease-free survival in stage III melanoma patients.

Kruijff S, Bastiaannet E, Kobold AC, van Ginkel RJ, Suurmeijer AJ, Hoekstra HJ. Kruijff S, et al. Among authors: bastiaannet e. Ann Surg Oncol. 2009 Dec;16(12):3455-62. doi: 10.1245/s10434-009-0629-8. Ann Surg Oncol. 2009. PMID: 19636631 Free PMC article.

8

Detection of melanoma nodal metastases; differences in detection between elderly and younger patients do not affect survival.

Kruijff S, Bastiaannet E, Suurmeijer AJ, Hoekstra HJ. Kruijff S, et al. Among authors: bastiaannet e. Ann Surg Oncol. 2010 Nov;17(11):3008-14. doi: 10.1245/s10434-010-1085-1. Epub 2010 May 5. Ann Surg Oncol. 2010. PMID: 20443146 Free PMC article.

9

The value of pre operative S-100B and SUV in clinically stage III melanoma patients undergoing therapeutic lymph node dissection.

Kruijff S, Bastiaannet E, Speijers MJ, Kobold AC, Brouwers AH, Hoekstra HJ. Kruijff S, et al. Among authors: bastiaannet e. Eur J Surg Oncol. 2011 Mar;37(3):225-32. doi: 10.1016/j.ejso.2010.12.013. Epub 2011 Jan 31. Eur J Surg Oncol. 2011. PMID: 21277729

10

Long-term follow-up reveals that ulceration and sentinel lymph node status are the strongest predictors for survival in patients with primary cutaneous melanoma.

de Vries M, Speijers MJ, Bastiaannet E, Plukker JT, Brouwers AH, van Ginkel RJ, Suurmeijer AJ, Hoekstra HJ. de Vries M, et al. Among authors: bastiaannet e. Eur J Surg Oncol. 2011 Aug;37(8):681-7. doi: 10.1016/j.ejso.2011.05.003. Epub 2011 Jun 1. Eur J Surg Oncol. 2011. PMID: 21636244 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

251 results

Search Page

Filters